click below
click below
Normal Size Small Size show me how
Pharm Unit 13
SPC Pharmacology Unit 13 Exam 5
Question | Answer |
---|---|
What is the purpose of a Mucolytic? | Breaks down mucus |
What is mucus? | a chain of amino sugars and amino acids linked together by disulfide bonds 95% water carbohydrates, lipids, glycoproteins |
Mucolytic may promote what in asthmatics? | Severe bronchospasm in asthmatics |
Mucolytic short term or long term use? | Short term 3-5 days then re-evaluate to determine need. |
Mucomyst is an Antioxidant | free radical scavenger |
What should be done after use of Mucomyst? | Rinse mouth after each use |
What in more detail is the purpose of Mucomyst? | Lysis (disrupts) disulfide bonds Lowers mucus viscosity and elasticity |
Why cant mucomyst be given to nauseated patients? | it smells and may promote nausea and vomiting |
Allergy history to sulfides/sulfur is? | Not a contraindication to inhalation of mucomyst (n-acetylcysteine) |
Mucomyst is compatible with? | Sympathomimetics |
Mucomyst is not compatible with? | Antibiotics |
What solutions are available to a mucolytic? | 10% and 20% |
Which is recommended 10% or 20% solution? | 10% is recommended because it has a lesser incidence of side effects and clinically equally effective |
Dornase Alfa also known as? | Pulmozyme |
Pulmozyme | thins infectious mucus by disrupting the DNA bonds found in infectious mucus which makes it very vicous |
HCA (Health Care Worker) should.... | Avoid inhalation during administration due to effects of DNA |
How long can Pulomzyme be at room temperature? | No more than 24hrs or throw away |
Pulmozyme ampoule must be... | Clear and Refrigerated. |
When should Pulmozyme be administered? | Immediately after opening |
T/F Pulmozyme should be administered in a dedicated nebulizer? | True |
Don't breath it, administer it | Pulmozyme |
Avoid if patient is on sodium restrictions or has metabolic alkalosis. | Sodium Bicarbonate |
Sodium Bicarbonate is a? | Benign Mucolytic |
Sodium Bicarbonate is administered by? | Instillation or Nebulization |
Isotonic | 0.9% |
Hypotonic | <0.9% Incidence of airway irritation is significantly less than other solutions |
Hypertonic | >0.9% Promotes cough, may cause bronchospasm |
Potassium Iodide (SSKI) | Reduces mucus elasticity and has a direct mucolytic effect |
Surface Tension | Opposes Inspiration Opposed Alveolar Expansion Reduces stability of alveolus The force that resists the inflation of the alveolus (lung cant inflate) |
Surfacant | Is a complex mixture of lipids and proteins produced by Type II cells. (Reduces surface tension) Lowers Surface tension so lung can inflate |
Natural Surfactants | Potential Viral Infection Expensive Time Consuming to Prepare |
Synthetic Surfactants | Free potential infectious agents Reduced Efficacy (response) Less costly Easy to Acquire |
Dosing of Surfactants | Direct Instillation |
Hazards of instillation of Surfactants | Airways obstruction Bradycardia Desaturation |
The Surfactant Layer does what? | Promotes homogenous gel layer Prevents water loss from sol layer |
Where is the surfactant layer? | Between the gel and the sol layer |
Adverse reactions to Pulmozyme.... | Chest pain, irritation/inflammation of the eye, mouth, laryngitis |
The goal of Surfactants | Reduce surface tension Promote lung inflation |